NCT00440518 - A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Migraine

Interventions

DRUG

Lacosamide

Lacosamide 100mg immediate-release film-coated tablet (white,oval) oral administration twice daily 12 hours apart

OTHER

Placebo

Immediate-release film coated tablet (white, oval), oral administration twice daily 12 hours apart

DRUG

Lacosamide

Lacosamide 300mg, immediate-release film coated tablet (white,oval), oral administration twice daily 12 hours apart.

Trial Locations (24)

12205

Albany

27401

Greensboro

28105

Matthews

30094

Conyers

33143

South Miami

33351

Sunrise

33410

Palm Beach Gardens

35801

Huntsville

37203

Nashville

44121

Cleveland

48104

Ann Arbor

63141

St Louis

65807

Springfield

72205

Little Rock

77004

Houston

78258

San Antonio

80304

Boulder

98122

Seattle

Unknown

Walnut Creek

Evansville

Oklahoma City

Alexandria

02481

Wellesley Hills

01605

Worcester